United States · FDA National Drug Code directory
Vyndaqel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-1975_67f1031d-c298-4cf9-9051-bb8f99e56442
- Product NDC
- 0069-1975
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- tafamidis meglumine
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190516 / 20270731
Source-listed ingredients
- TAFAMIDIS MEGLUMINE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 CARTON (0069-1975-40) / 30 BLISTER PACK in 1 CARTON / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-1975-12) · 0069-1975-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →